Asymmetric Synthesis of b-Substituted a-Methylenebutyrolactones via TRIP-Catalyzed Allylation
2003, 42, 3927–3930; T. Hamada, K. Manabe, S. Ko-
bayashi, Angew. Chem. 2003, 115, 4714; Angew. Chem.
Int. Ed. 2003, 42, 4565; b) M. Fujita, T. Nagano, U.
Schneider, T. Hamada, C. Ogawa, S. Kobayashi, J. Am.
Chem. Soc. 2008, 130, 2914–2915; c) S. Kobayashi, T.
Endo, U. Masaharu, Angew. Chem. 2011, 123, 12470–
12473; Angew. Chem. Int. Ed. 2011, 50, 12262–12265;
d) K. Takeuchi, T. Takeda, T. Fujimoto, I. Yamamoto,
Tetrahedron 2007, 63, 5319–5322.
[16] A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Kno-
chel, Angew. Chem. 2006, 118, 6186–6190; Angew.
Chem. Int. Ed. 2006, 45, 6040–6044.
[17] a) J. Fischer, A. J. Reynolds, L. A. Sharp, M. S. Sher-
burn, Org. Lett. 2004, 6, 1345–1348; b) B. Raffaelli, K.
Wahala, T. Hase, Org. Biomol. Chem. 2006, 4, 331–341.
[18] a) N. M. Saarinen, R. Huovinen, A. Warri, S. I. Makela,
L. Valentin-Blasini, L. Needham, C. Eckerman, Y. U.
Collan, R. Santti, Nutr. Cancer 2001, 41, 82–90;
b) N. M. Saarinen, A. Warri, S. I. Makela, C. Eckerman,
M. Reunanen, M. Ahotupa, S. M. Salmi, A. A. Franke,
L. Kangas, R. Santti, Nutr. Cancer 2000, 36, 207–216.
[19] a) D. Ingram, D. Sanders, M. Kolybaba, D. Lopez,
Lancet 1997, 350, 990–994; b) N. M. Saarinen, R. Huo-
vinen, A. Wꢇrri, S. I. Mꢇkelꢇ, L. Valentꢈn-Blasini, R.
Sjçholm, J. ꢉmmꢇlꢇ, R. Lehtilꢇ, C. Eckerman, Y. U.
Collan, R. S. Santti, Mol. Cancer Ther. 2002, 1, 869–
876.
[10] a) T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew.
Chem. 2004, 116, 1592–1594; Angew. Chem. Int. Ed.
2004, 43, 1566–1568; b) T. Akiyama, H. Morita, J. Itoh,
K. Fuchibe, Org. Lett. 2005, 7, 2583–2585.
[11] a) D. Uraguchi, K. Sorimachi, M. Terada, J. Am. Chem.
Soc. 2004, 126, 11804–11805; b) D. Uraguchi, K. Sori-
machi, M. Terada, J. Am. Chem. Soc. 2005, 127, 9360–
9361; c) D. Uraguchi, M. Terada, J. Am. Chem. Soc.
2004, 126, 5356–5357.
[12] a) T. Akiyama, Chem. Rev. 2007, 107, 5744–5758;
b) A. G. Doyle, E. N. Jacobsen, Chem. Rev. 2007, 107,
5713–5743; c) M. Terada, Synthesis 2010, 1929–1982;
d) M. Terada, Chem. Commun. 2008, 4097–4112; e) J.
Yu, F. Shi, L.-Z. Gong, Acc. Chem. Res. 2011, 44, 1156–
1171; f) A. Zamfir, S. Schenker, M. Freund, S. B. Tso-
goeva, Org. Biomol. Chem. 2010, 8, 5262–5276.
[13] S. Hoffmann, A. M. Seayad, B. List, Angew. Chem.
2005, 117, 7590–7593; Angew. Chem. Int. Ed. 2005, 44,
7424–7427.
[20] a) M. N. Grayson, S. C. Pellegrinet, J. M. Goodman, J.
Am. Chem. Soc. 2012, 134, 2716–2722; b) H. Wang, P.
Jain, J. C. Antilla, K. N. Houk, J. Org. Chem. 2013, 78,
1208–1215.
[21] a) G. Ercolani, L. Schiaffino, J. Org. Chem. 2011, 76,
2619–2626; b) Y. Zhao, D. G. Truhlar, Acc. Chem. Res.
2008, 41, 157–167; the method is known to accurately
describe main group elements, but was recently also
successfully used for Zn-mediated reactions.
[22] The splitting into the two parts results in two charged
subunits, which probably leads to overestimated stabili-
zation energies due to the lack of dissipation of charge
in the surroundings. However, the high energy indicates
that the uncoordinated species is significantly less
stable.
[14] P. Jain, J. C. Antilla, J. Am. Chem. Soc. 2010, 132,
11884–11886.
[15] a) N. Momiyama, H. Tabuse, M. Terada, J. Am. Chem.
Soc. 2009, 131, 12882–12883; b) F.-L. Sun, M. Zeng, Q.
Gu, S.-L. You, Chem. Eur. J. 2009, 15, 8709–8712; c) M.
Terada, K. Soga, N. Momiyama, Angew. Chem. 2008,
120, 4190–4193; Angew. Chem. Int. Ed. 2008, 47, 4122–
4125.
[23] SaxRalcS refers to: Sax =axial chirality of catalyst is (S);
R
alc =alcohol is (R)-configured, S=configuration at the
chiral center formed in the lactone ring.
Adv. Synth. Catal. 0000, 000, 0 – 0
ꢁ 2013 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7
ÞÞ
These are not the final page numbers!